Codiak BioSciences, Inc. General and Administrative Expense
Codiak BioSciences, Inc. reported General and Administrative Expense of $6.56 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2022-11-03
- Codiak BioSciences, Inc. general and administrative expense for the quarter ending 2022-09-30 was $6.56M, a 8.67% decline year-over-year.
- Codiak BioSciences, Inc. general and administrative expense for the quarter ending 2022-06-30 was $7.36M, a 6.16% increase year-over-year.
- Codiak BioSciences, Inc. general and administrative expense for the quarter ending 2022-03-31 was $6.71M, a 1.81% increase year-over-year.
- Codiak BioSciences, Inc. general and administrative expense for the quarter ending 2021-12-31 was $6.92M, a 16.88% increase year-over-year.
- Codiak BioSciences, Inc. general and administrative expense for fiscal 2021 was $27.63M, a 39.17% increase from fiscal 2020.
- Codiak BioSciences, Inc. general and administrative expense for fiscal 2020 was $19.85M, a 5.64% decline from fiscal 2019.
- Codiak BioSciences, Inc. general and administrative expense for fiscal 2019 was $21.04M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $6.56M 10-Q · filed 2022-11-03 | $13.93M derived: sum of 2 quarters · filed 2022-11-03 | $20.63M 10-Q · filed 2022-11-03 | $27.55M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $7.36M 10-Q · filed 2022-08-04 | $14.07M 10-Q · filed 2022-08-04 | $20.99M derived: sum of 3 quarters · filed 2022-08-04 | $28.18M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $6.71M 10-Q · filed 2022-05-05 | $13.63M derived: sum of 2 quarters · filed 2022-05-05 | $20.81M derived: sum of 3 quarters · filed 2022-11-03 | $27.75M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $14.10M derived: sum of 2 quarters · filed 2022-11-03 | $21.04M derived: sum of 3 quarters · filed 2022-11-03 | $27.63M 10-K · filed 2022-03-10 |
| 2021-09-30 | $7.19M 10-Q · filed 2022-11-03 | $14.12M derived: sum of 2 quarters · filed 2022-11-03 | $20.71M 10-Q · filed 2022-11-03 | $26.63M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $6.94M 10-Q · filed 2022-08-04 | $13.53M 10-Q · filed 2022-08-04 | $19.44M derived: sum of 3 quarters · filed 2022-08-04 | $24.79M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $6.59M 10-Q · filed 2022-05-05 | $12.51M derived: sum of 2 quarters · filed 2022-05-05 | $17.85M derived: sum of 3 quarters · filed 2022-05-05 | $22.21M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $11.26M derived: sum of 2 quarters · filed 2022-03-10 | $15.62M derived: sum of 3 quarters · filed 2022-03-10 | $19.85M 10-K · filed 2022-03-10 |
| 2020-09-30 | $5.34M 10-Q · filed 2021-11-04 | $9.70M derived: sum of 2 quarters · filed 2021-11-04 | $13.93M 10-Q · filed 2021-11-04 | $18.19M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $4.36M 10-Q · filed 2021-08-05 | $8.59M 10-Q · filed 2021-08-05 | $12.84M derived: sum of 3 quarters · filed 2021-08-05 | $17.68M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $4.23M 10-Q · filed 2021-05-06 | $8.49M derived: sum of 2 quarters · filed 2021-05-06 | $13.32M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $9.09M derived: sum of 2 quarters · filed 2021-03-17 | $21.04M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $4.83M 10-Q · filed 2020-11-19 | $16.79M 10-Q · filed 2020-11-19 |